Auteur ZIEDONIS D. M.

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Addressing tobacco use through organizational change: a case study of an addiction treatment organization

ZIEDONIS D. M. ; L. ZAMMARELLI ; SEWARD G. ; K. OLIVER ; J. GUYDISH ; M. HOBART ; MELTZER B. | 2007
Dans Journal of Psychoactive Drugs (Vol.39 n°4, 2007) Article : Périodique

ENGLISH : Compared to the general population, persons entering addiction treatment are three to four times more likely to be tobacco dependent and even addiction treatment staff members are two to three times more likely to be tobacco dependen[...]

Plus d'info

Ajouter à la sélection

Applicability of the Fagerström test for nicotine dependence in smokers with schizophrenia

M. L. STEINBERG ; J. M. WILLIAMS ; H. R. STEINBERG ; J. A. KREJCI ; ZIEDONIS D. M. | 2005
Périodique

ENGLISH : Up to 90% of individuals with schizophrenia smoke cigarettes, and many show signs of heavy dependence. Although the severity of nicotine dependence is often measured by the six-item Fagerström Test for Nicotine Dependence (FTND), thi[...]

Plus d'info

Ajouter à la sélection

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience

L. AMASS ; W. LING ; T. E. FREESE ; C. REIBER ; J. J. ANNON ; A. J. COHEN ; D. McCARTY ; M. S. REID ; L. S. Jr BROWN ; C. CLARK ; ZIEDONIS D. M. ; J. KREJCI ; STINE S. ; T. WINHUSEN ; G. BRIGHAM ; D. BABCOCK ; MUIR J. A. ; B. J. BUCHAN ; T. HORTON | 2004
Dans American Journal on Addictions (Vol.13, Suppl.1, May-June 2004) Article : Périodique

In October 2002, the US Food and Drug Administration approved buprenorphine-naloxone (Suboxone) sublingual tablets as an opioid dependence treatment available for use outside traditionally licensed opioid treatment programs. The NIDA Center for [...]

Plus d'info

Ajouter à la sélection

Lien externe

Comorbid psychopathology and cocaine addiction

ZIEDONIS D. M. | 1992
Chapitre

FRANÇAIS : Il existe une liaison interactive entre la consommation de cocaïne et les troubles psychopathologiques, mais leurs manifestations sont extrêmement hétérogènes (troubles cognitifs, psychoses, anxiété, dépression). Il est important de [...]

Plus d'info

Ajouter à la sélection

Practice guideline for the treatment of patients with substance use disorders. Second Edition

American Psychiatric Association ; Work group on substance use disorders ; H. D. KLEBER ; R. D. WEISS ; R. F. ANTON ; T. P. GEORGE ; S. F. GREENFIELD ; T. R. KOSTEN ; OBRIEN C. P. ; B. J. ROUNSAVILLE ; E. C. STRAIN ; ZIEDONIS D. M. ; HENNESSY G. ; H. SMITH CONNERY | 2006
Rapport

The Practice Guideline for the Treatment of Patients With Substance Use Disorders, 2nd Edition, consists of three parts (A, B, and C) and many sections, not all of which will be equally useful for all readers. The following guide is designed t[...]

Plus d'info

Ajouter à la sélection

Lien externe

The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey

J. M. WILLIAMS ; FOULDS J. ; M. DWYER ; ORDER-CONNORS B. ; SPRINGER M. ; GADDE P. ; ZIEDONIS D. M. | 2005
Périodique

ENGLISH : New Jersey was the first state to implement a licensure standard for all residential addiction treatment programs to assess and treat tobacco dependence in the context of entirely tobacco-free facilities (including grounds). A progra[...]

Plus d'info

Ajouter à la sélection

Treatment of patients with substance use disorders, second edition

American Psychiatric Association ; Work group on substance use disorders ; Steering committee on practice guidelines ; H. D. KLEBER ; R. D. WEISS ; R. F. ANTON ; T. P. GEORGE ; S. F. GREENFIELD ; T. R. KOSTEN ; C. P. O'BRIEN ; B. J. ROUNSAVILLE ; E. C. STRAIN ; ZIEDONIS D. M. ; HENNESSY G. ; H. S. CONNERY ; J. S. McINTYRE ; S. C. CHARLES ; D. J. ANZIA ; I. A. COOK ; M. T. FINNERTY ; B. R. JOHNSON ; NININGER J. E. ; P. SUMMERGRAD ; S. M. WOODS ; YAGER J. ; PYLES R. ; C. D. CROSS ; R. PEELE ; SHEMO J. P. ; L. LURIE ; R. D. WALKER ; M. A. BARNOVITZ ; S. H. GRAY ; S. SAXENA ; TONNU T. ; KUNKLE R. ; A. B. ALBERT ; FOCHTMANN L. J. ; C. HART ; D. REGIER | 2007
Dans American Journal of Psychiatry (Vol.164, n°4 Suppl., 2007) Article : Périodique

Individuals with substance use disorders are heterogeneous with regard to a number of clinically important features and domains of functioning. Consequently, a multimodal approach to treatment is typically required. Care of individuals with subs[...]

Plus d'info

Ajouter à la sélection

Lien externe